Polygiene AB (publ.) Stock Nasdaq Stockholm
Equities
SE0007692157
Specialty Chemicals
Sales 2023 | 114M 10.4M | Sales 2024 * | 128M 11.75M | Capitalization | 291M 26.63M |
---|---|---|---|---|---|
Net income 2023 | -304M -27.85M | Net income 2024 * | -4M -366K | EV / Sales 2023 | 2.33 x |
Net cash position 2023 | 40.26M 3.69M | Net cash position 2024 * | 34M 3.11M | EV / Sales 2024 * | 2 x |
P/E ratio 2023 |
-1
x | P/E ratio 2024 * |
-72.4
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 39.11% |
Managers | Title | Age | Since |
---|---|---|---|
Ulrika Bjork
CEO | Chief Executive Officer | 56 | 17-05-09 |
Niklas Blomstedt
DFI | Director of Finance/CFO | - | 22-09-14 |
Sue Bethel
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 56 | 18-12-31 | |
Director/Board Member | 71 | 23-05-10 | |
Daniel Röme
CTO | Chief Tech/Sci/R&D Officer | 48 | 17-12-31 |
1st Jan change | Capi. | |
---|---|---|
+9.99% | 62.37B | |
-6.50% | 45.17B | |
+13.40% | 40.11B | |
+17.90% | 25.95B | |
+1.03% | 17.71B | |
-0.59% | 17.23B | |
+5.78% | 15.71B | |
-29.39% | 14.27B | |
-22.38% | 13.18B |